Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$9.44 -0.05 (-0.58%)
As of: Nov 11, 2026 · 9:47 AM EST

Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026)

Updated

Syndax Pharmaceuticals (SNDX) recorded Finished Goods of $1.17 million in Q3 2026, down 47.4% from $2.22 million a year earlier and down 23.8% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Finished Goods (2024 - 2026) Analysis & Trends

At the end of FY2025, Syndax Pharmaceuticals reported Finished Goods of $1.62 million.

  • Across earlier years, Finished Goods came in at $36,000 in FY2024.
  • The Q3 2026 figure is the lowest quarterly Finished Goods since Q4 2024.
  • On a year-over-year basis, Finished Goods has declined for three consecutive quarters.
  • Per Business Quant, the preceding three quarters came in at $1.53 million (Q2 2026), $1.38 million (Q1 2026) and $1.62 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Syndax Pharmaceuticals 854.00 Mn -867.10 Mn 69.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.17 Mn
Jun 30, 2026 1.53 Mn
Mar 31, 2026 1.38 Mn
Dec 31, 2025 1.62 Mn
Sep 30, 2025 2.22 Mn
Jun 30, 2025 2.25 Mn
Mar 31, 2025 2.35 Mn
Dec 31, 2024 36,000.00
API Access

Syndax Pharmaceuticals Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=SNDX&period=max&api_key=YOUR_API_KEY